Press enter to activate the dialog and use the tab key to navigate through the options.

Glaukos Corporation Company Logo
  1. Top Workplaces
  2. Glaukos Corporation

Glaukos Corporation

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness.

The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in 2012 and is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression.

The company’s second-generation MIGS device, the iStent inject® Trabecular Micro-Bypass System, was approved by the Food and Drug Administration, or FDA in June 2018. The company believes the iStent inject,® measuring 0.23 mm wide and 0.36 mm long, is the smallest medical device ever approved by the FDA.
... Read more


Our mission is to pioneer and lead the global glaucoma market with micro-scale injectable therapies that advance the existing glaucoma standard-of-care and enrich the lives and treatment alternatives for glaucoma patients worldwide.... Read more

Additional Culture Details

We are an ambitious, innovative group of professionals that are focused on giving back to our community, having humility, working hard and along the way improving the lives of patients with glaucoma . We describe each other, "like family" and that goes for us having fun together to being there for each other in times of need. Our employees can donate PTO to help each other out in the hard times and we have fun events to celebrate the good. We are dedicated to the mission of the organization and believe in our leadership and the direction of the company.... Read more

Recent Awards